Stocks hold lower on Thursday morning in shaky trading one day before the inauguration of President-elect Donald Trump.
Analysts really liked the streaming giant's stellar fourth quarter results, with many increasing their price targets.
Sorry investors, your post-election honeymoon is about to be over: at noon tomorrow, the Trump rally will get real.
What you need to know.
Insiders at these companies -- including Kindred Biosciences and Regeneron Pharmaceuticals -- have been scooping up shares of their own stock lately.
The former governor of Texas begins his confirmation hearing for the job he once said he would abolish.
These charts explain it all.
Here are the must-know details affecting one of the U.S.' largest railroads.
There could be a major windfall for Fortune 500 companies.
A Trump administration could make precious metals an investor's best friend.
Fed speakers are sounding to hawkish and need to tone it down, according to Real Money contributor Stephen Guilfoyle.
Pfizer is working on its eighth straight loss after failing near heavy resistance.
The retailer has lowered its guidance for fiscal fourth-quarter profit and revenue following a weak November and December.
The South Korean tech giant has struggled in recent months with malfunctioning products and a political scandal involving the company's vice chairman.
Should you get on board with railroad stocks? Here's what Jim Cramer thinks.
Jim Cramer says GE could move higher even sooner if it adopts a plan put forth by activist fund manager Nelson Peltz.
Jim Cramer says Magellan Midstream Partners is "the best-run pipeline company in the country" at a time when America is about to inaugurate a president who favors pipelines.
BofA/Merrill Lynch downgraded the stock to 'neutral' based on valuation.
Shares of Tesla were gaining over 3% after an upgrade to over-weight at Morgan Stanley on Thursday.
'Cash on hand,' or more specifically, lack of it, is putting millions of Americans in financial peril.
Jim Cramer says not to expect a breakout quarter from Procter & Gamble because the strong dollar will likely weigh on results. But don't sell just yet.
Alden Global reduced its stake in Pier 1 to 4.3%, noting a combination of factors.
Check out Jim and TheStreet editorial team’s latest analysis and commentary on what’s moving markets now.